ATEZOLIZUMAB PLUS BEVACIZUMAB

Clinical trials for ATEZOLIZUMAB PLUS BEVACIZUMAB explained in plain language.

Never miss a new study

Get alerted when new ATEZOLIZUMAB PLUS BEVACIZUMAB trials appear

Sign up with your email to follow new studies for ATEZOLIZUMAB PLUS BEVACIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo therapy shows promise for Tough-to-Treat liver cancer

Disease control Not yet recruiting

This study tests a new treatment for people with liver cancer that cannot be removed by surgery. It combines low doses of two drugs (bevacizumab and atezolizumab) with a procedure that delivers chemotherapy directly to the liver. The goal is to see if this approach can shrink tum…

Matched conditions: ATEZOLIZUMAB PLUS BEVACIZUMAB

Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control

Last updated Apr 30, 2026 15:51 UTC

ATEZOLIZUMAB PLUS BEVACIZUMAB

Get alerted when new ATEZOLIZUMAB PLUS BEVACIZUMAB trials appear

New combo therapy shows promise for Tough-to-Treat liver cancer